NervGen Pharma
NGEN1.6000.63% ( +0.010 )
NervGen Pharma (NGEN)
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous syst...
- Open
- 1.600
- High
- 1.660
- Low
- 1.590
- Prev. Close
- 1.590
- Volume
- 221.47K
- Turnover
- 359.94K
- Avg Price
- 1.625
- Bid/Ask Ratio
- --
- Amplitude
- 4.40%
- 52wk High
- 6.300
- Volume Ratio
- 0.28
- Turnover Ratio
- 0.32%
NervGen Pharma Analyst Rating
View MoreForecast & Rating
Jul 14, 2026Price forecast
$10.60562.77%
Forecast & RatingBuy
8analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · Jul 14 at 05:50 AM
This Halliburton Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
- PUBT · Jul 2 at 04:24 PM
NervGen Pharma launches US$ 50 million at-the-market equity offering via Leerink Partners
- Tip Ranks · Jun 11 at 08:46 AM
H.C. Wainwright Reaffirms Their Buy Rating on NervGen Pharma (NGEN)
- benzinga_article · May 26 at 07:33 AM
Why Is NervGen Pharma Stock Gaining Tuesday?
- StockTitan · May 25 at 10:15 PM
NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study | NGEN Stock News
- Tip Ranks · May 24 at 01:15 PM
NervGen Pharma (NGEN) Receives a Buy from Stifel Nicolaus
